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Abstract
We have prepared unique macroporous and ordered dextran-based hydrogels using a single-step biocatalytic transesterification
reaction between dextran and divinyladipate in neat dimethylsulfoxide. These hydrogels show a unimodal distribution of
interconnected pores with average diameters from 0.4 to 2.0 mm depending on the degree of substitution. In addition, the hydrogels
show a higher elastic modulus for a given swelling ratio than chemically synthesized dextran-based hydrogels. In vivo studies in rats
show that the hydrogel networks are degradable over a range of time scales from 5 to over 40 days, and possess good
biocompatibility, as reflected in only a mild inflammatory reaction and minor fibrous capsule formation during the time-frame of
subcutaneous implantation. These combined properties may offer competitive advantages in biomedical applications ranging fromring to controlled drug delivery.r 2004 Elsevier Ltd. All rights reserved.
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1. Introduction
The site-selective proliferation of cells and the
modulation of cellular function at implantable sites
require the controlled release of biologically active
macromolecules, including peptides, proteins, and
DNA [1–3]. These molecules must be incorporated into
biocompatible, and ultimately erodable/biodegradable,
matrices that provide for useful materials properties
while maintaining biologically relevant functionality.s potential use as scaffolds to deliver cells to
omic sites, create and maintain a space for
pment, and guide tissue formation before
ed [4]. These desired properties have served
e front matter r 2004 Elsevier Ltd. All rights reserved.
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ateriais, Rua do Campo Alegre 823, 4150-180 Porto,as the driving force for the use of a wide range of
synthetic matrices that are biocompatible and erodable/
biodegradable, including aliphatic polyesters, such as
poly(glycolic acid) (PGA) and poly(lactic acid) (PLA),
polyanhydrides, and the use of natural matrices such as
collagen, among others [5,6]. However PGA and PLA
are stiff materials, which make them in general less
suitable as matrices for soft tissue engineering [6], while
bovine collagen has potential risks for disease transmis-
sion [7].
Polysaccharide hydrogels, particularly those based on
dextran, may be an alternative to the aforementioned
polymers especially for soft tissue engineering applica-
tions. These glucose-based polymers are available in a
wide range of molecular weights and contain a high
density of hydroxyl groups that make the polymers
highly hydrophilic and capable of being further functio-
nalized chemically or enzymatically. Dextran is also
biocompatible and can be degraded through the action
of dextranases in various organs in the human body,
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ateriaincluding liver, spleen, kidney, and colon [8]. Unfortu-
nately, hydrogels prepared from complex precursors
such as sugars and polysaccharides typically consist of
heterogeneous microstructures with variable physico-
chemical properties [9,10]. This is particularly severe for
hydrogels that contain a wide pore size distribution
resulting in variable release profiles of large biomole-
cules and non-uniform materials properties leading to
poor degradability [11,12]. Furthermore, in some cases,
hydrogels may promote fibrous capsule formation upon
implantation in vivo precluding their general use as
scaffolds and implantable drug delivery systems [13–15].
In the present work we describe a biocatalytic strategy
to obtain unique macroporous and ordered dextran-
based hydrogels, which involves a single-step transester-
ification reaction between dextran and divinyladipate
(DVA) in neat dimethylsulfoxide (DMSO). This reac-
tion is highly surprising given the strong denaturing
capacity of DMSO, yet regioselective dextran acylation
and gel formation ensues. The resulting hydrogels are
degradable at physiologic pH, do not form substantial
fibrous capsule when implanted subcutaneously in rats,
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based hydrogels obtained chemically. The biocatalytic
route, therefore, leads to a novel material that cannot be
synthesized using more traditional chemical techniques.
2. Materials and methods
2.1. Materials
The protease (EC 3.4.21.62) from Bacillus subtilis
(Proleather FG-F) was a gift from Amano Enzyme Ltd.
(Troy, VA). The other enzymes used in this work were
commercially available and the suppliers are listed in
Supplementary Material Table 1. DVA was purchased
Table 1
Network properties of dextran-DVA hydrogels obtained either chemically o
Initial molar ratio of
DVA to dextran (%)
Biocatalytic hydrogelsa
DS (%)b DSmonoester (%)
c DSdiester
40 30.173.4 8.8 21.3
50 30.771.8 8.8 21.9
60 32.870.5 8.8 24.0
aThe hydrogels were purified in milli-Q water (pH –7), at 4 1C for 10 days, c
temperature under vacuum until constant weight was attained, and analyzed
bDefined as the number of DVA molecules incorporated into dextran th
residues (average7SD, n ¼ 3).
cDefined as the number of DVA molecules incorporated into dextran thro
100 dextran glucopyranoside residues (as determined by FTIR; see materials
value of 8.8 represents the number of DVA molecules incorporated into dex
residues. This number was obtained from a 6000Da dextran substrate rea
accurate NMR vinyl group analysis was performed because the smaller dext
dDefined as the difference between DS and DSmonoester.from TCI America (Portland, OR). Dextran (from
Leuconostoc mesenteroides; Mn ¼ 39; 940;
Mw ¼ 70; 000Da) was obtained from Fluka Chemie
AG (Buchs, Switzerland). 4-Dimethylaminopyridine (4-
DMAP) was purchased from Aldrich (Milwaukee, WI).
Solvents were dried over molecular sieves for at least
24 h prior to use to remove residual water. The water
content in DMSO was measured by Karl–Fischer
titration and was below 0.06% (v/v) H2O. Other
chemicals and solvents were of the highest grade
commercially available.
2.2. Enzyme screening for the transesterification reaction
of dextran with DVA
The enzymes were ‘‘pH-adjusted’’ prior to use, in the
presence of 20mM phosphate buffer at pH 8.0 (Pro-
leather, Protease S, and subtilisin Carlsberg) or at pH
7.5 (Proteases A, N, and P, and Lipases A, AY, M, PS,
and Porcine Pancreas). After being flash-frozen in liquid
nitrogen, the samples were lyophilized on a Labconco
freeze-drier (Labconco Corp., Kansas City, MO) for
48 h. Proleather thermally deactivated or inhibited by
PMSF were prepared as described previously [16].
Reactions were performed in 15mL of anhydrous
DMSO containing dextran Mw ¼ 70 kDa (1 g), 0.20M
DVA and 300mg of ‘‘pH-adjusted’’ enzymes (except for
subtilisin Carlsberg, which was employed at 150mg).
The reaction mixtures were shaken at 50 1C and 250 rpm
for 72 h (except 48 h for Proleather FG-F and lipases
AY and PS).
2.3. Proleather FG-F catalyzed synthesis of dextran-
PRESS
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Dextran (1 g, 1.0mM) and different concentrations of
DVA (0.041–0.41M) were dissolved in 15mL DMSO
r enzymatically
Chemical hydrogelsb
(%)d DS (%)b DSmonoester (%)
c DSdiester (%)
d
25.171.4 14.9 10.2
27.170.2 14.6 12.5
29.071.1 14.1 14.9
hanging the water daily. Afterwards, the hydrogels were dried at room
by FTIR.
rough single or double ester bonds per 100 dextran glucopyranoside
ugh a single ester bond containing both a free carboxyl end group per
and methods) and a calculated vinyl ester end group. The calculated
tran containing a terminal vinyl ester moiety per 100 glucopyranoside
cted with DVA (as was done with the 70,000Da dextran) for which
ran substrate did not form a gel.
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leather. The reaction mixtures were shaken at 50 1C and
250 rpm for 72 h. In the reaction mixtures that did not
gel, the solutions were centrifuged at 4000 rpm for
10min and the supernatants mixed with water (3:7, v/v)
and dialyzed (MWCO 50,000; Spectrum, CA) against
HC1 aqueous solution pH 3.0 for 7 days and then for
three additional days against milli-Q water at 4 1C.
Afterwards the aqueous solutions were freeze-dried for
48 h (isolated yields between 60% and 85%). In reaction
mixtures that did gel, the resulting gels were separated
from the glass beakers and immersed in milli-Q water, at
4 1C for 10 days, changing the water daily. Afterwards,
the gels were cut in disc-shape sections with a thickness
of 0.4–0.6 cm, dried at room temperature under vacuum
in the presence of phosphorous pentoxide until constant
weight was attained (isolated yields between 72% and
87%). The degree of substitution (DS) of dextran
derivatives (either in the gel or non-gel form) was
determined by FTIR, taking into account the ratio of
the absorption bands at 1730 cm1 (ester, v ðCQOÞ)
and 760 cm1 (dextran). DS is defined as the number of
DVA molecules incorporated into dextran through
single or double ester bonds per 100 dextran glucopyr-
anoside residues. The ratio (A1730/A760) values were then
converted into DS using a calibration curve of dextran,
Mw ¼ 6 kDa; derivatized with different concentrations
of DVA (water-soluble compounds), where DS was
calculated using 1H NMR spectroscopy. In this case,
DS ¼ ½ð7 xÞ=ð4 yÞ  100; where x is the integral of
the adipate protons in the range of d 2.47–1.64 ppm and
y is the integral of all dextran protons between d 5.56
and 3.20 ppm.
2.4. Chemical synthesis of dextran-DVA
Dextran (1 g, 1.0mM) and different concentrations of
DVA (0.041–0.41M) were dissolved in 15mL DMSO
and the reaction commenced by adding 4-DMAP
(200mg). The reaction mixtures were shaken at 50 1C
and 250 rpm for 72 h. In the reaction mixtures that
gelled, the resulting products were separated from the
glass beakers and immersed in milli-Q water adjusted
to pH 3.0, for 10 days at 4 1C, changing the water
daily. Afterwards, the hydrogels were dried at room
temperature, under vacuum, until constant weight was
attained.
2.5. SEM and MIP analyses
Swollen dextran-DVA hydrogels were quickly frozen
in a glass container using liquid nitrogen and freeze-
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corresponding to half-diameter of each hydrogel, were
mounted into aluminium stud and gold coated by
plasma vapor deposition. The surface and cross-sectionof the gels were recorded by a field emission electron
microscope (JEOL model JSM-5310) at 15–20 kV.
Mercury porosimetry (Micromeritics Poresizer 9320)
was used to determine the bulk density, skeletal density,
porosity, and pore size distribution. All samples were
degassed before analysis at a vacuum pressure below
50mmHg. High pressure runs (from 25 to 30,000 psia)
were made with an equilibration time of 20 s and a
maximum intrusion volume of 0.05mL/g. The poro-
grams (intruded volume versus pressure) obtained were
converted into pore diameter distribution curves (cu-
mulative and differential) according to the Washburn
equation [17], pd ¼ 4r cos y, where p is the pressure
required to force mercury into a pore of entry diameter
d, r is the surface tension (485 dyncm1), and y is the
contact angle between mercury and the sample (1301).
The porosity of hydrogels was calculated from the
equation: porosity ¼ [(skeletal density-bulk density)/
skeletal density] l00.
2.6. In vitro degradation studies
Dried dextran-DVA hydrogels, accurately weighed
(Wi), were immersed in 10mM phosphate buffer saline
(PBS) pH 7.4. At different times they were removed,
lyophilized on a freeze drier (FTS System, NY) for 24 h
and weighed (Wt). After Wt determination, either
swelling ratio (SR ¼ ðW s  W tÞ=W t where Ws is the
weight of swollen hydrogel and Wt is the weight of dried
hydrogel) or mass remaining [(Wt/Wi) 100] were
calculated. Then, the DS and DSmonoester (defined as
the number of DVA molecules incorporated to dextran
through single ester bonds, and hence retaining a
carboxylic moiety, per 100 dextran glucopyranoside
residues) were determined by FTIR spectroscopy. The
DSmonoester was calculated as the ratio between the
absorbance at 1560 cm1 (stretching of the COO
group) and at 760 cm1 (dextran). The ratio was
then converted into DSmonoester after using a calibration
curve of sodium adipate and dextran in different molar
ratios.
2.7. In vivo biocompatibility studies
European community guidelines (No. 86/609/CE;
corresponding to decree No. 1005/92 of Portuguese
legislation) for the care and use of laboratory animals
were observed. Male Wistar rats (8–12-week old) were
anesthetized, with Ketalars (50mg kg1, Parke-Davis)
and an area of the front was shaved and washed with
Betadines. Two incisions along the spine (ca. 1 cm in
length) were made and two subcutaneous pockets were
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previously UV-sterilized and swollen in citrate-phos-
phate pH 5.0, were placed into the pocket away from the
incision (ca. 0.5 cm) and the skin was closed with
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area was washed with Betadines dermic solution and
the rats kept warm with a heating pad for 1 h after the
surgical procedure and finally transferred to a cage.
Three rats were used for each time point. As a control,
subcutaneous pockets were made without implants. At
certain times, the rats were sacrificed and the implants
with surrounding tissue where carefully dissected and
fixed in 4% (v/v) neutral buffered formalin, for at least 3
days. The blocks were sliced perpendicular or cross-
sectional to the implanted hydrogels. The implant and
adjacent tissue were oriented and placed in processing
cassettes, taken through a graded ethanol series
(Shandon Citadel 1000) and embedded in paraffin.
The samples were then sectioned using a microtome
(Shandon Retraction AS 325), and finally deparaffinized
and stained either with hematoxylin/eosin, periodic
acid-schiff, or Masson’s trichrome [18]. Multiple photo-
ARTICLE
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tissues using a Nikon microscope (Eclipse E 600) with a
Nikon camera (FOX-35). The tissue response was rated
by two persons.
Fig. 1. Proleather-catalyzed acylation of dextran with DVA. (A) Synthesis
DVA (initial molar ratio of DVA to dextran glucopyranose residues of 50%)
30mg/mL (&)] and in the absence of enzyme (,) or in the presence of therm
indicate the reaction times at which gelation was observed. (C) Swelling ratio
course transesterification reactions [Proleather concentration of 20mg/mL (J
water for 10 days at 4 1C.3. Results and discussion
3.1. Enzymatic synthesis of dextran-based hydrogels
Native dextran is soluble in water or very polar
organic solvents such as DMSO; however, only in the
latter can enzyme-catalyzed transesterification of dex-
tran be performed without undesirable ester hydrolysis.
Eleven enzymes (Table 1 of supplementary Material),
chosen from a group of hydrolases that are known to
catalyze the acylation of simple sugars or other
polysaccharides in organic media [12,16,19–21], were
screened for their abilities to catalyze the acylation of
dextran (Mw ¼ 70; 000) with DVA (Fig. 1A). Three of
the enzymes gave appreciable conversion, with an
alkaline protease from B. subtilis (Proleather FG-F)
and two lipases (from C. rugosa and P. cepacia) yielding
458% conversion of the dextran. Furthermore, each of
PRESS
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did not form in control reactions in the absence of
enzyme or in the presence of the aforementioned
enzymes in the absence of DVA. FTIR spectra (Fig. 1
scheme. (B) DS as a function of time for the reaction of dextran with
in the presence of active Proleather [10mg/mL (n), 20mg/mL (J) and
ally deactivated Proleather (}) (10mg/mL). The arrows in the graph
(SR) measurements of dextran-DVA hydrogels prepared in the time-
) and 30mg/mL (&)] following extensive washing procedures in milli-Q
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ateriaof Supplementary Material) of the gels confirmed the
presence of carbonyl groups (peak at 1730 cm1) arising
from the DVA molecules attached to dextran. To
complement these results, CP/MAS 13C NMR spectro-
scopy was undertaken (Fig. 1 of Supplementary
Material), and provided evidence of the carbonyl carbon
at d 175.8 ppm and the adipate carbons at d 32.5 and
25.9 ppm further confirming the transesterification of
dextran with DVA.
All three enzymes were active in the organic solvent,
which was surprisingly given the well-known deactiva-
tion of enzymes in neat DMSO [22,23]. To confirm that
the transesterification reaction was indeed enzymatic,
several control reactions were performed using Pro-
leather as the most reactive enzyme. Limited sponta-
neous reaction (conversion o15% with no gel
formation) was observed in the absence of enzyme or
with thermally deactivated Proleather over a period of
72 h (Fig. 1B). Enzyme pre-inactivated by the serine
protease inhibitor phenylmethanesulfonyl fluoride
(PMSF) also gave minimal reactivity and again no gel
formation was observed. The enzyme activity was not
due to an underlying contaminant in the commercial
preparation, as SDS-PAGE revealed only one signifi-
cant protein band (data not shown).
The ability of Proleather to remain active while
dissolved in DMSO was strongly dependent on the
nature of the enzyme preparation. The commercial
Proleather preparation contains only ca. 13% (w/w)
protein being the remaining fraction formed by maltose
(data provided by manufacturer). Upon dialysis to
increase the protein content to 18% (w/w) the dextran
conversion was reduced 1.6-fold compared to the crude
enzyme preparation. Proleather was also active in
DMSO on simple compounds related to dextran,
including the simple sugar O-methyl-a-D-glucoside.
ARTICLE
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and maltotriose, Proleather activity in DMSO increased
(Table 2 of Supplementary Material). Specifically, the
activity of Proleather was over 20-fold higher on
Table 2
Characteristics of swollen dextran-DVA hydrogels with different DS as mea
Sample DS (%) Volume of mercury
intruded (mL/g)
A
(m
Biocatalytic hydrogels 28 8.98 2.
30 8.17 1.
31 5.12 0.
47 4.86 0.
Chemical 27 1.09 25
hydrogels 29 1.01 35
aCalculated as ((skeletal densitybulk density)/skeletal density) 100.
bUnimodal distribution: value corresponding to the mode of the peak.
cBimodal distribution: values corresponding to the mode of the peaks. Se
dDetermined at 1.5mL/g in the figure of log differential intrusion versus pmaltotriose than on O-methyl-a-D-glucoside. While it
is difficult to compare directly the reactivity of
Proleather on simple sugars versus polysaccharides,
these results nonetheless suggest that the presence of
sugars of increasing size (including the polysaccharide
dextran itself) help stabilize Proleather in the soluble
state in DMSO and may play a role in enabling
transesterification reactions to be performed.
3.2. Physical characterization of enzymatically generated
dextran hydrogels
The time course of Proleather-catalyzed dextran
acylation is depicted in Fig. 1B, where a rapid increase
is observed in DS. This is concomitant with a decrease in
the equilibrium swelling ratio of the hydrogels (Fig. 1C),
which continues even past the point of an observable
increase in the extent of acylation, and a substantial
decrease in average pore diameter from ca. 21–6 mm, at
24 and 72 h of reaction time, according to scanning
electron microscopy (SEM) results (data not shown).
This is likely due to the rapid acylation of dextran with
DVA followed by a slower intra- and/or intermolecular
reaction of the second vinyl ester group of DVA with
another part of the dextran chain or other dextran
chains to form adipate crosslinks.
The elastic modulus of hydrogels ranged from 1.4 kPa
for hydrogels prepared with a DS of 20% to 5.8 kPa for
hydrogels prepared with a DS of 47%, as measured by
an indentation method [19]. Interestingly, the hydrogels
prepared biocatalytically show a higher elastic modulus
for a given swelling ratio than dextran-based hydrogels
synthesized by others chemically. For example, for
hydrogels with calculated polymer volume fractions of
0.04–0.05, the elastic modulus of dextran biocatalytic
hydrogels is twice as high than that of a gel obtained via
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[24] (4.9 versus 2.2 kPa) and 4-fold higher than dextran-
methacrylate hydrogels [25] (2.6 versus 0.6 kPa). For
a more direct comparison, dextran was acylated
sured by MIP
verage pore diameter
m)
Pore size distribution Porosity
(%)a
0b 3.5–0.18d 89.0
7b 3.2–0.21d 86.3
72b 1.0–0.21d 82.8
38b 0.65–0.17d 80.1
/0.3c —c 67.8
/0.15c —c 66.5
e Fig. 2 for pore size distribution.
ore diameter.
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ateriachemically with DVA using 4-DMAP [25] as catalyst in
DMSO at 50 1C. Hydrogel formation required 40% DS,
in contrast to 20% needed for gel formation in the
enzymatic process. Even at 40% DS, the chemically
generated hydrogels were fragile and easily fragmented
preventing modulus determination.
Because the biocatalytic hydrogels were mechanically
stronger than the chemical ones, our results suggest that
Proleather catalysis favors the formation of a greater
number of intermolecular crosslinks as compared to the
chemical route. The low number of intermolecular
crosslinks in the 4-DMAP-catalyzed reaction is likely
due to the lower efficiency of this catalyst to promote the
attachment of both of the terminal vinyl ester groups of
DVA into dextran. Indeed, the biocatalytically gener-
ated hydrogels contained up to twice as many diester
adipate crosslinks (at the expense of the less productive
monoester linkages) than the chemically generated
hydrogels. This is clearly seen by inspection of Table
1, where the DSdiester content in the biocatalytically
generated hydrogels are on average ca. 2.5-fold higher
than the DSmonoester for all ratios of DVA to dextran.
Conversely, the chemically generated hydrogels favor
the DSmonoester by ca. 1.2-fold. Many of the diester
crosslinks are likely to be intermolecular, and hence the
biocatalytic hydrogels are stronger than those prepared
chemically at the same total degree of substitution.
Differences between the enzymatically and chemically
(DMAP catalyzed) synthesized dextran-DVA hydrogels
were further highlighted using SEM analysis of the
resulting gel networks (Fig. 2). The biocatalytic dextran
hydrogels had more uniform pore sizes than those of
ARTICLE
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organization of biocatalytic hydrogels was also con-
firmed by mercury intrusion porosimetry (MIP) analysis
(Fig. 2E). The hydrogels showed a unimodal distribu-
Fig. 2. Scanning electron micrographs (SEM) and mercury intrusion porosim
surface of swollen dextran-DVA hydrogels in 10mM citrate-phosphate pH 5
(D). Hydrogels were obtained either enzymatically (A,B) or chemically (C,D)
diameter of dextran-DVA hydrogels obtained enzymatically (J) or chemication of pores with average diameters from 0.4 to 2.0 mm
(Table 2). The average pore diameter decreased as the
DS of hydrogel increased, which was expected given the
higher crosslink density at higher DS values. The sharp
peaks of the porograms show that the pore size
distribution is narrow and relatively homogeneous. In
contrast, chemically synthesized dextran-DVA hydro-
gels showed a bimodal distribution of pores and
therefore were relatively heterogeneous, with the major-
ity of pores above 25 mm in size (Fig. 2F and Table 2). In
addition, as clearly shown by the low content of mercury
intruded (Fig. 2F and Table 2), these hydrogels present a
lower number of pores than biocatalytic hydrogels.
Finally, the porosity values on biocatalytic hydrogels
were above 80% and therefore higher than those
obtained on dextran-DVA hydrogels synthesized che-
mically (porosity values below 68%). The high porosity
values on biocatalytic hydrogels show that hydrogels are
formed by an interconnected structure, which may make
these networks attractive for tissue engineering applica-
tions where porosities above 80% are desired for tissue
integration [26].
The structural organization of biocatalytic dextran-
DVA hydrogels is also distinct from chemically synthe-
sized dextran-based hydrogels reported in the literature.
For example, Kim and Chu [10] showed a bimodal
distribution of pore sizes either in mesopore or
macropore regions between the surface and interior of
dextran-methacrylate hydrogels. Such heterogeneity was
explained by different degrees of crosslinking during
photopolymerization of the dextran-methacrylate hy-
drogel precursor, caused by a differential UV-penetra-
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homogeneity in dextran-DVA hydrogels obtained en-
zymatically may be at least partly due to the regioselec-
tivity achieved in the enzymatic process [19] and the
etry distribution from dextran-based hydrogels. (A–D) SEM from the
.0, after being previously dried: DS 28% (A), 30% (B), 27% (C), 29%
. (E,F) Plot of pore size distribution (log differential intrusion) against
lly (&).
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ateriauniform crosslinking of the dextran promoted by a
homogeneous distribution of the biological catalyst.
3.3. Biocompatibility and degradation studies
Biocompatibility of the dextran-based hydrogels was
assessed via subcutaneous implantation in rats, using
ARTICLE
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intensity of the inflammatory response to these foreign
implants was monitored histologically and qualitatively
interpreted. Representative light micrographs of dex-
Fig. 3. Hydrogel implantation studies. Representative light micrographs of de
subcutaneously and surrounding tissue at different times, stained with hema
schiff (E). (A) At day 2, a moderate inflammatory reaction is observed su
neutrophils, adhered to the hydrogel and they were surrounded by fibrin (f) a
fibroblasts surrounded the hydrogel DS 31%, while collagen (c) was found un
surrounding tissue. (C,D) At day 10, the hydrogel DS 31% was surrounded b
involved by fibroblast cells and collagen. These macrophages were not observ
completely degraded and macrophages (MØ) containing internalised hydroge
hydrogel. (F,G) At day 40, the hydrogel DS 47% undergoes degradation a
surrounding the hydrogel. These cells were surrounded by collagen (c), wh
Magnifications are 100 for A and F, 50 for B–D and G, and 250 fortran-DVA DS 31% and DS 47% hydrogels implanted
subcutaneously are presented in Fig. 3. In general, the
dextran-based hydrogels appeared to show good in vivo
biocompatibility at least under the limited conditions of
this study. The inflammatory response (during the first
5/10 days; Figs. 3A and B) was mild with all hydrogels.
Granulocyte and lymphocyte cells, as well exudate and
PRESS
ls 26 (2005) 4707–4716 4713fibrin, completely disappeared by day 10. The wound
healing response to the implants consisted initially of
macrophages eroding the hydrogel surface, fibroblasts
depositing collagen into the region of the implant, and
xtran-DVA DS 31% (A–E) and DS 47% (D,F,G) hydrogels implanted
toxylin/eosin (A,D,F), Masson’s trichrome (B,C,G) and periodic acid-
rrounding the hydrogel DS 31% (H): granulocytes (arrow), mainly
nd exudate (e). (B) At day 5, a cell layer (arrow) formed essentially by
derneath the cell layer. Newly blood vessels (v) were also present at the
y several layers of hydrogel-containing macrophages (MØ), which were
ed in hydrogel DS 47% (D). (E) At day 20, the hydrogel DS 31% was
l particles (arrows) were observed at the place originally occupied by the
nd macrophages (MØ) as well foreign body cells (FBG) are observed
ich was either (F) or not (G) organised in a minor fibrous capsule.
E.
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ateriathe presence of few foreign body giant (FBG) cells
formed by fusion of macrophages, particularly in high
DS dextran-DVA hydrogels. These tissue responses are
consistent with those observed in other biocompatible
hydrogel implants (e.g., crosslinked gelatin and metha-
crylated dextran hydrogels) [15,27].
The influence of DS was clearly evident in subcuta-
neous implantation. Hydrogel-containing macrophages
were observed at 5, 10, and 40 days post-implantation
for hydrogels with DS values of 28%, 31%, and 47%,
respectively. These cells contained hydrogel particles, as
confirmed by periodic acid-Schiff staining (Fig. 3E),
which suggests a phagocytosis process. As expected, this
phenomenon begins earlier for hydrogels with lower DS,
primarily because of the smaller number of crosslinks
and the more rapid degradability. FBG cells were
observed mainly in the hydrogel with a DS of 47%
(Fig. 3F). The high number of FBG cells in this highly
crosslinked network is likely due to its rough surface
[27]. A layer of collagen-depositing fibroblasts was
observed surrounding the macrophage and FBG cells.
This collagen layer begins to organize visually into a
fibrous capsule by day 10, both with hydrogels DS 31%
ARTICLE
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For hydrogel DS 31% the network subsequently
degrades (see below), and therefore, no mature fibrous
capsule is formed, while for hydrogel DS 47% a
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Fig. 4. Erodability of dextran-based hydrogels. Swelling ratio (A), mass rem
28% (n), 31% (O) and 47% (&) as a function of time, when immersed in 1discontinuous fibrous capsule is observed (Figs. 3F
and G). In this last case, in most regions the collagen
strands are low in number and loosely organized (Fig.
3G) yielding little or no clear boundary between the
hydrogel implant and the surrounding tissue. The lack
of fully intact fibrous capsule formation is relatively
unique in comparison to other non-degradable [14,15]
and degradable [27,28] hydrogels, which favor the
formation of fibrous capsule when implanted in vivo.
This also compares favorably with other dextran-based
hydrogels described elsewhere [29], where a continuous
and compact fibrous capsule was observed after 4 weeks
post-implantation. The incomplete fibrous capsule for-
mation in the dextran-DVA gels is critical in supporting
ultimate gel integration within the surrounding tissue.
Hydrogels DS 28%, 31%, and 47% were degraded
between 5 and 10 days, 20, and 30 days, and440 days,
respectively. It is likely that the hydrogel degradation is
mainly caused by the hydrolysis of the ester linkage of
the crosslink molecules, as observed in the in vitro
studies. Fig. 4A shows the swelling behavior of dextran-
DVA hydrogels as a function of time, when incubated in
10mM PBS at pH 7.4. The hydrogels showed a
PRESS
ls 26 (2005) 4707–4716progressive swelling in time, which in case of dextran-
DVA DS 28% and 31% was followed by a dissolution
phase (in case of hydrogels DS 47%, further time was
needed to accomplish dissolution). The increased swel-
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0mM PBS pH 7.4, at 37 1C (average7SD, n ¼ 3).
The online version of this article contains additional
IN
aterialing is likely a consequence of the hydrolysis of
crosslinks (adipate groups) in the hydrogel network (as
depicted by a loss in DS with time in Fig. 4C) and not
dextran, which is stable at this pH [30]. When crosslinks
in the network are cleaved, the network swells and
imbibes more water. Furthermore, as the adipate groups
hydrolyze to yield single ester bonds onto the dextran
and free carboxyl moieties (Fig. 4D), the ionized
carboxyl groups will increase the swelling behavior of
the hydrogel upon Donnan equilibrium is achieved. As
expected, hydrogels with higher DS and higher number
of intermolecular crosslinks tend to hydrolyze slower
than ones with lower DS. The mass loss of dextran-
DVA hydrogels was also monitored as a function of
time. As shown in Fig. 4B, the mass loss was minimal
for SR values below 30 (o10% for dextran-DVA DS
28% and 31% hydrogels), albeit dramatic when hydro-
gels achieved their maximum swelling (SR of 35–40). In
this last case, dextran chains bear few crosslinks per
chain and hydrogels start to disintegrate quickly. This
indicates that the hydrolysis of dextran-DVA hydrogels
occurs through a bulk erosion mechanism. A similar
ARTICLE
L. Ferreira et al. / Biomhydrolysis mechanism was observed for poly(glycolic
acid)/poly(lactic acid) polymers [6] and poly(propylene
fumarate-co-ethylene glycol) hydrogels [28], among
others.
4. Conclusions
We have shown that selected enzymes are able to
catalyze the synthesis of dextran-based hydrogels in a
single step, enabling the formation of macroporous,
structurally organized hydrogels with superior mechan-
ical properties to dextran-based hydrogels obtained
chemically. These hydrogels are degradable at physio-
logic pH, do not form substantial fibrous capsule when
implanted subcutaneously in rats, and may find
applications as cell-carriers (scaffolds) or implantable
biomolecule delivery vehicles. Moreover, the technique
employed is simple, involves commercially available
enzymes and reagents, and should be suitable with a
wide range of abundant polysaccharides.
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